HRS/BHB-1893, a Next-Generation Cardiac Myosin Inhibitor, Improves Indices of Diastolic Function in Non-Obstructive Hypertrophic Cardiomyopathy: Evidence from in vitro Studies and Patients (AHA 2026) - Sep 5, 2026 - Abstract #10712; Pres time: Nov 6, 2026; 10:15 AM - 10:25 AM; Location: S406A; "Abstract is embargoed at this time."
Preclinical • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy • Non-obstructive Hypertrophic Cardiomyopathy
|
|
Carlos del Rio, Braveheart Bio, San Mateo, CA; Limei Wang, Mo Zhang, Xueyi Wu, Xin Quan, Qing Wei, Mingyao Li, Hongquan Lu, Mingzhao Du, shumin zhang, XIANGYU ZHANG, Lianjun Xu, dong wang, lei song, Wen Jiang, Lianming Kang, Fuwai Hosp,Chinese Acad of Medical Sciences and Peking Union Medical Coll, Beijing, China; Cassady Rupert, Propria LLC, Branford, CT; Amy Feng, Braveheart Bio, Encino, CA; Emil deGoma, Braveheart Bio, San Francisco, CA; Xiaoyi Sun, Qi Sheng, Jiangsu Hengrui Pharmaceuticals Co, Ltd, Shanghai, China; Marc Evanchik, Braveheart Bio, San Francisco, CA
|